Healthy Adult
Conditions
Interventions
Daily ingestion 30 ml of sea buckthorn juice for 4 weeks.
Daily ingestion 30 ml of placebo juice for 4 weeks.
Sponsors
Hokkaido Information University
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Subjects who agree to participate in this study with a written informed consent. 2. Postmenopausal females between 50 and 65 years old. 3. Subjects who feels poor sleep quality. 4. Subjects who feels fatigue.
Exclusion criteria
Exclusion criteria: 1. Subjects who are under physician's advice, treatment, and/or medication for insomnia, depression, Parkinson's disease, mood disorder, sleep apnea syndrome, nocturnal polyuria, overactive bladder, hypertension, dyslipidemia and/or diabetes, etc. 2. Subjects who regularly use medicines that inhibit blood clotting and/or gastric acid secretion. 3. Subjects who frequently go to the toilet at night. 4. Subjects with suspected sleep apnea syndrome. 5. Subjects whose lifestyle is expected to change. 6. Subjects who use pacemakers and/or defibrillators. 7. Subjects with serious cerebrovascular, cardiac, hepatic, renal, gastrointestinal, respiratory diseases, and/or affected with infectious diseases requiring reports to the authorities. 8. Subjects with major surgical history relevant to the digestive system. 9. Subjects with unusually high and/or low blood pressure, abnormal physical data and/or abnormal hematological data. 10. Subjects with severe anemia. 11. Post-menopausal women complaining of obvious physical changes, or subjects who are under physician's advice, treatment, and/or medication for menopausal symptoms. 12. Subjects who are at risk of having allergic reactions to drugs and/or foods especially based on milk, Asteraceae, Elaeagnaceae. 13. Subjects who regularly take medicine, functional foods which would affect sleep, fatigue, and/or frequent urination. 14. Subjects who regularly take sea buckthorn. 15. Heavy smokers, alcohol addicts and/or subjects with disordered lifestyle. 16. Subjects who donated either 400 ml whole blood within 16 wks, 200 ml whole blood within 4 wks, or blood components within 2 wks, prior to this study. 17. Pregnant or lactating women or women who expect to be pregnant. 18. Subjects who currently participate in other clinical trials, or participated within the last 4 wks prior to this study. 19. Subjects who are ineligible due to physician's judgment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| OSA sleep inventory MA version after 4 weeks of ingestion. | — |
Secondary
| Measure | Time frame |
|---|---|
| VAS questionnaire, The Brief Job Stress Questionnaire (Section B), Pittsburgh Sleep Quality Index, Overactive Bladder Symptom Score. | — |
Countries
Japan
Contacts
Public ContactNaoyuki HONMA
Hokkaido Information University Health Information Science Center
Outcome results
None listed